Diagnostics & Research
The Diagnostics & Research industry has a total of 44 stocks, with a combined market cap of $813.06 billion, total revenue of $172.71 billion and a weighted average PE ratio of 44.95.
Market Cap
813.06B
Revenue
172.71B
Profits
18.09B
PE Ratio
44.95
Profit Margin
10.47%
Dividend Yield
0.21%
44 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 225.48B | 1.10% | 1,789,672 | 46.34B |
| 2 | DHR | Danaher Corporation | 140.70B | -0.19% | 684,638 | 25.11B |
| 3 | NTRA | Natera, Inc. | 47.41B | 0.86% | 798,059 | 2.71B |
| 4 | IQV | IQVIA Holdings Inc. | 42.49B | 0.34% | 273,527 | 16.98B |
| 5 | A | Agilent Technologies, Inc. | 41.42B | 2.66% | 1,775,558 | 7.37B |
| 6 | WAT | Waters Corporation | 40.12B | 1.67% | 487,179 | 4.64B |
| 7 | IDXX | IDEXX Laboratories, Inc. | 39.76B | -0.36% | 401,630 | 4.55B |
| 8 | ILMN | Illumina, Inc. | 31.17B | 2.57% | 2,412,388 | 4.49B |
| 9 | DGX | Quest Diagnostics Incorporated | 25.94B | 1.68% | 997,028 | 11.56B |
| 10 | MTD | Mettler-Toledo International Inc. | 25.84B | 0.70% | 15,152 | 4.13B |
| 11 | LH | Labcorp Holdings Inc. | 25.27B | 1.49% | 809,932 | 14.35B |
| 12 | GH | Guardant Health, Inc. | 21.12B | -1.04% | 695,840 | 1.18B |
| 13 | MEDP | Medpace Holdings, Inc. | 16.40B | 0.75% | 159,487 | 2.78B |
| 14 | RVTY | Revvity, Inc. | 13.87B | 2.79% | 1,151,504 | 2.91B |
| 15 | CRL | Charles River Laboratories International, Inc. | 13.22B | 1.40% | 93,660 | 4.00B |
| 16 | ICLR | ICON Public Limited Company | 13.06B | 2.18% | 1,710,005 | 8.29B |
| 17 | QGEN | Qiagen N.V. | 8.71B | - | 122,819 | 2.10B |
| 18 | RDNT | RadNet, Inc. | 5.94B | 1.63% | 610,327 | 2.27B |
| 19 | SHC | Sotera Health Company | 5.20B | -0.22% | 171,706 | 1.22B |
| 20 | BLLN | BillionToOne, Inc. | 4.66B | 0.26% | 406,010 | 397.41M |
| 21 | ADPT | Adaptive Biotechnologies Corporation | 3.86B | -0.12% | 1,238,261 | 308.08M |
| 22 | GRAL | GRAIL, Inc. | 3.40B | -1.71% | 360,986 | 165.26M |
| 23 | VCYT | Veracyte, Inc. | 3.29B | -1.12% | 131,643 | 561.90M |
| 24 | CDNA | CareDx, Inc. | 2.60B | 0.48% | 663,050 | 458.09M |
| 25 | WGS | GeneDx Holdings Corp. | 2.54B | 1.55% | 331,596 | 454.43M |
| 26 | NEO | NeoGenomics, Inc. | 2.23B | -1.65% | 1,072,053 | 766.30M |
| 27 | PSNL | Personalis, Inc. | 1.73B | -0.73% | 1,407,019 | 69.67M |
| 28 | FRNM | Freenome, Inc. | 1.54B | -2.84% | 538,461 | 35.41M |
| 29 | OPK | OPKO Health, Inc. | 1.17B | 5.37% | 5,180,777 | 587.90M |
| 30 | CSTL | Castle Biosciences, Inc. | 974.83M | -1.27% | 35,967 | 357.28M |
| 31 | FLGT | Fulgent Genetics, Inc. | 551.13M | -0.45% | 63,968 | 323.93M |
| 32 | MYGN | Myriad Genetics, Inc. | 327.12M | 1.79% | 2,552,909 | 806.60M |
| 33 | BDSX | Biodesix, Inc. | 284.51M | 3.55% | 47,060 | 102.94M |
| 34 | XGN | Exagen Inc. | 170.30M | 0.86% | 476,716 | 71.12M |
| 35 | IMDX | Insight Molecular Diagnostics Inc. | 137.44M | 5.53% | 173,826 | 1.67M |
| 36 | BNR | Burning Rock Biotech Limited | 128.67M | 4.99% | 46,560 | 73.70M |
| 37 | QUCY | Quantum Cyber N.V. | 112.65M | -2.19% | 371,148 | 537.08K |
| 38 | MDXH | MDxHealth SA | 67.23M | 4.23% | 259,056 | 114.02M |
| 39 | PRPO | Precipio, Inc. | 47.17M | -2.08% | 21,926 | 27.20M |
| 40 | ADVB | Advanced Biomed Inc. | 13.53M | -9.04% | 16,348 | - |
| 41 | NDRA | ENDRA Life Sciences Inc. | 8.43M | -2.94% | 5,762 | - |
| 42 | XWEL | XWELL, Inc. | 8.29M | 2.34% | 5,441 | 28.28M |
| 43 | BIAF | bioAffinity Technologies, Inc. | 4.29M | -15.34% | 827,861 | 5.90M |
| 44 | ISPC | iSpecimen Inc. | 3.70M | -2.00% | 182,073 | 466.30K |